LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 39.71 | 21.74 | 3826 | 3084 | 1.2405 | 1.0612 | MN20160310_N01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 39.71 | 21.74 | 3876 | 3084 | 1.2568 | 1.0650 | MN20160310_N01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 41.68 | 21.74 | 4429 | 3418 | 1.2955 | 1.0722 | MN20160310_N01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 41.68 | 21.74 | 4814 | 3418 | 1.4081 | 1.0960 | MN20160310_N01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 41.68 | 21.74 | 4192 | 3418 | 1.2262 | 1.0567 | MN20160310_N01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 41.68 | 21.74 | 4238 | 3418 | 1.2396 | 1.0598 | MN20160310_N01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 43.65 | 21.74 | 5057 | 3754 | 1.3470 | 1.0818 | MN20160310_N01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 43.65 | 21.74 | 5334 | 3754 | 1.4208 | 1.0968 | MN20160310_N01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 43.65 | 21.74 | 4601 | 3754 | 1.2256 | 1.0555 | MN20160310_N01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 43.65 | 21.74 | 4647 | 3754 | 1.2378 | 1.0582 | MN20160310_N01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 45.62 | 21.74 | 5635 | 4150 | 1.3576 | 1.0823 | MN20160310_N01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 45.62 | 21.74 | 5830 | 4150 | 1.4045 | 1.0917 | MN20160310_N01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 45.62 | 21.74 | 5096 | 4150 | 1.2277 | 1.0549 | MN20160310_N01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 45.62 | 21.74 | 5179 | 4150 | 1.2477 | 1.0593 | MN20160310_N01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 47.59 | 21.74 | 5986 | 4492 | 1.3326 | 1.0761 | MN20160310_N01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 47.59 | 21.74 | 6300 | 4492 | 1.4025 | 1.0899 | MN20160310_N01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 47.59 | 21.74 | 5565 | 4492 | 1.2388 | 1.0565 | MN20160310_N01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 47.59 | 21.74 | 5626 | 4492 | 1.2524 | 1.0594 | MN20160310_N01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 49.56 | 21.74 | 6533 | 4838 | 1.3501 | 1.0785 | MN20160310_N01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 49.56 | 21.74 | 6707 | 4838 | 1.3861 | 1.0855 | MN20160310_N01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 49.56 | 21.74 | 6022 | 4838 | 1.2445 | 1.0569 | MN20160310_N01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 49.56 | 21.74 | 6090 | 4838 | 1.2586 | 1.0599 | MN20160310_N01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 51.53 | 21.74 | 6964 | 5150 | 1.3520 | 1.0779 | MN20160310_N01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 51.53 | 21.74 | 7167 | 5150 | 1.3914 | 1.0855 | MN20160310_N01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 51.53 | 21.74 | 6442 | 5150 | 1.2507 | 1.0575 | MN20160310_N01 | K07 |